Using gene delivery tools to understand and treat skeletal muscle-related disease
Using gene delivery tools to understand and treat skeletal muscle-related disease
批准号:
nhmrc : 1046782
负责人:
A/Pr Paul Gregorevic
金额:
$30.62万
依托单位国家:
澳大利亚
项目类别:
Career Development Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As a muscle biologist, I study the mechanisms that regulate skeletal muscle size, so that we can develop therapies for muscle wasting. What sets my research apart is my combination of expertise in muscle biology, and the use of recombinant viral vectors for altering the expression of specific genes exclusively in skeletal muscles. Our approaches enable us to study the inner workings of muscles in ways others cannot, and develop promising new therapies for treating muscle diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rescuing the dystrophin-glycoprotein complex to protect muscles from wasting conditions
-
批准号:nhmrc : GNT1144772
-
项目类别:Project Grants
-
资助金额:$83.33万
-
财政年份:2018
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Rescuing the dystrophin-glycoprotein complex to protect muscles from wasting conditions
-
批准号:nhmrc : 1144772
-
项目类别:Project Grants
-
资助金额:$56.35万
-
财政年份:2018
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
The effects of ACTN3 R577X on muscle wasting and repair, and response to therapy
-
批准号:nhmrc : 1130215
-
项目类别:Project Grants
-
资助金额:$72.83万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Investigating follistatin-based interventions for long term-protection against frailty associated with chronic illness and aging
-
批准号:nhmrc : GNT1121500
-
项目类别:Project Grants
-
资助金额:$98.72万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Investigating follistatin-based interventions for long term-protection against frailty associated with chronic illness and aging
-
批准号:nhmrc : 1121500
-
项目类别:Project Grants
-
资助金额:$67.47万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Using gene delivery technologies to define novel mechanisms of skeletal muscle adaptation, and develop muscle-directed interventions for frailty and serious illness
-
批准号:nhmrc : GNT1117835
-
项目类别:Research Fellowships
-
资助金额:$63.14万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
The effects of ACTN3 R577X on muscle wasting and repair, and response to therapy
-
批准号:nhmrc : GNT1130215
-
项目类别:Project Grants
-
资助金额:$106.61万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Using gene delivery technologies to define novel mechanisms of skeletal muscle adaptation, and develop muscle-directed interventions for frailty and serious illness
-
批准号:nhmrc : 1117835
-
项目类别:Research Fellowships
-
资助金额:$43.17万
-
财政年份:2017
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Pre-clinical assessment of the therapeutic potential of targeting the Hippo pathway in muscle wasting & muscle-derived cancer
-
批准号:nhmrc : GNT1099588
-
项目类别:Project Grants
-
资助金额:$62.2万
-
财政年份:2016
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Pre-clinical assessment of the therapeutic potential of targeting the Hippo pathway in muscle wasting & muscle-derived cancer
-
批准号:nhmrc : 1099588
-
项目类别:Project Grants
-
资助金额:$42.65万
-
财政年份:2016
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Novel Muscle Therapeutics Through Selective Beta-Adrenoceptor Signalling
-
批准号:nhmrc : 1026231
-
项目类别:Project Grants
-
资助金额:$40.25万
-
财政年份:2012
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Investigating Hippo signalling as a novel cause of muscle disease, and as a target for new interventions to combat frailty
-
批准号:nhmrc : 1009995
-
项目类别:Project Grants
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Defining mechanisms of follistatin-mediated muscle adaptation, for treatment of frailty and muscle-related diseases
-
批准号:nhmrc : 526648
-
项目类别:NHMRC Project Grants
-
资助金额:$37.17万
-
财政年份:2009
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
Targeting beta-adrenergic signalling to improve muscle regeneration in muscular dystrophy
-
批准号:nhmrc : 509313
-
项目类别:NHMRC Project Grants
-
资助金额:$31.55万
-
财政年份:2008
-
负责人:A/Pr Paul Gregorevic
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位: